top of page

Insights

​

​

insights.jpg

Rare Disease Innovator Briefings

​

​

​

​​

​​

​

Rare neuromuscular diseases and PROMs: The impact of payer and reimbursement authorities evidence requirements on healthcare solution design: link

​

A novel valuation model for medical intervention development: link

​

​

Patient power – the importance of patients and patient associations in Rare Disease intervention design and validation: link

 

​

A common apothecary cabinet – redesigning personalised medicines for Rare and age related diseases: link

​

​

A Cloud or a Perfect Storm? Assessing current status and future needs in Digital Health: link

 

​

Maximising outputs from early stage collaborations: how to make an optimal international R&D ecosystem organisation: link

 

​

2090..or 2020 – the future of regenerative medicine: link

​

The relevance of reimbursement rates and approved solution applicability on ROI: reassess your risk: link

​

​

Addiction to legal products - Tobacco and Alcohol: market assessment and the need to have a functional prevention and treatment strategy. Link

 

​

A progress dependent dynamic valuation model for healthcare solution development. Link

 

​

Innovation case study (Transvac) – designing an international early stage innovation ecosystem: link

​

​

Socioeconomic needs – putting health value before financial gain: link

 

​

​

​

Frequent indications

 Innovator briefings

Digital Health Solutions 

Picture 1.png
bottom of page